NL-OMON46393尚未招募不适用
A PROspective, explorative cohort study to correlate CARdiac BIomarkers with late cardiac toxicity induced by radiotherapy alone or combined with anthracycline chemotherapy for hodgkin lymphoma (PROCARBI) - PROCARBI
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •To be eligible participating in this study, patients must meet all the following criteria:
- •* Previous history of Hodgkin or mediastinal non-Hodgkin lymphoma treated with mediastinal radiotherapy with or without anthracycline-containing chemotherapy
- •* Planned visit at the BETER clinic
- •* Written informed consent
- •* Age ><= 18 years
- •* With a minimum of 5 years of disease free survival
排除标准
- •4.3 * Exclusion criteria;Not currently under treatment for malignant disease (unless basal cell carcinoma)
研究者
相似试验
招募中
不适用
A PROspective, explorative cohort study to correlate CARdiac BIomarkers with late cardiac toxicity induced by radiotherapy alone or combined with anthracycline chemotherapy for hodgkin lymphoma (PROCARBI)NL-OMON29157Department of radiotherapy and cardiology of Erasmus MC200
招募中
不适用
A prospective cohort study regarding the correlation between gastrointestinal cancer and life-style related diseasesEsophageal cancer, Gastric cancer, Liver cancer, Colorectal cancer, Pancreatic cancer, Biliary cancer, disease in GI tractJPRN-UMIN000016748Gifu University Graduate School of Medicine, Gastroenterology4,000
尚未招募
不适用
A prospective, explorative cohort study to identify biomarkers of treatment response in oropharyngeal cancer.Oropharyngeal cancerNL-OMON27421Erasmus MC200
招募中
不适用
The prospective cohort study investigating the relationship between circulating CD271-positive mononuclear cells in acute coronary syndrome and secondary coronary eventsAcute coronary syndromeJPRN-UMIN000026512Kanazawa University100
进行中（未招募）
1 期
An exploratory, observational cohort study investigating commercially available treatments which may reduce the scab stage of recurrent herpes labialisEUCTR2005-001384-60-GBGlaxoSmithKline Consumer Healthcare36